Publication: 19

Publication: 19

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.

PubMed

DOI

Google Scholar

Citation:: Ann Oncol vol 18 (6) 1071-9

Year:: 2007
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: 792
Children:: None

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:
Grants:: CA03927, CA04326, CA07968, CA11789, CA12046, CA12449, CA26806, CA31946, CA32291, CA33601, CA35113, CA41287, CA45389, CA45808, CA47642, CA77440, CA77597, CA77651, CA77658

Corr. Author:
Authors:: N L Bartlett D Niedzwiecki J L Johnson J W Friedberg K B Johnson K van Besien A D Zelenetz B D Cheson G P Canellos

Networks:

Study: CALGB-59804
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 1/2

Keywords:: Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Bleomycin, Dacarbazine, Deoxycytidine, Disease-Free Survival, Dose-Response Relationship, Drug, Doxorubicin, Hodgkin Disease, Humans, Middle Aged, Neutropenia, Patient Selection, Polyethylene Glycols, Salvage Therapy, Survival Analysis, Thrombocytopenia, Treatment Outcome, Vinblastine